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Abstract
Background Controversy still exists on the effect that
obesity has on the morbidity and mortality in severe acute
pancreatitis (SAP). The primary purpose of this study was
to compare the mortality rate of obese versus nonobese
patients admitted to the ICU for SAP. Secondary goals
were to assess the potential risk factors for abdominal
compartment syndrome (ACS) and to investigate the per-
formance of validated scoring systems to predict ACS and
in-hospital mortality.
Methods A retrospective cohort of adults admitted to the
ICU for SAP was stratified by their body mass index (BMI)
as obese and nonobese. The rates of morbidity, mortality,
and ACS were compared by univariate and multivariate
regression analyses. Areas under the curve (AUC) were
used to evaluate the discriminating performance of severity
scores and other selected variables to predict mortality and
the risk of ACS.
Result Forty-five patients satisfied the inclusion criteria
and 24 (53 %) were obese with similar characteristics to
nonobese patients. Among all the subjects, 11 (24 %) died
and 16 (35 %) developed ACS. In-hospital mortality was
significantly lower for obese patients (12.5 vs. 38 %;
P = 0.046) even though they seemed to develop ACS more
frequently (41 vs. 28 %; P = 0.533). At multivariable
analysis, age was the most significant factor associated with
in-hospital mortality (odds ratio (OR) = 1.273; 95 %
confidence interval (CI) 1.052–1.541; P = 0.013) and
APACHE II and Glasgow-Imrie for the development of ACS
(OR = 1.143; 95 % CI 1.012–1.292; P = 0.032 and
OR = 1.221; 95 % CI 1.000–1.493; P = 0.05) respectively.
Good discrimination for in-hospital mortality was observed
for patients’ age (AUC = 0.846) and number of comorbid-
ities (AUC = 0.801). ACS was not adequately predicted by
any of the clinical severity scores (AUC = 0.548–0.661).
Conclusions Patients’ age was the most significant factor
associated with mortality in patients affected by SAP.
Higher APACHE II and Glasgow-Imrie scores were asso-
ciated with the development of ACS, but their discrimi-
nation performance was unsatisfactory.
Introduction
The clinical presentation of acute pancreatitis (AP) ranges
from mild edematous to severe acute necrotizing pancre-
atitis (SAP) [1]. Edematous pancreatitis usually resolves
without major consequences, whereas SAP is associated
with considerable morbidity and mortality [1]. The death
rate has significantly decreased over time, from 60 to 80 %,
during the early 20th century, to 20–30 % in recent years
[1–4]. Still, prediction of the clinical course of these
patients remains challenging. Several models are used to
stratify the severity of the disease at presentation [5–9], but
they lack sufficient predictive granularity [10, 11]. One of
the reasons for this limitation is the fact that they may not
capture all of the relevant preexisting medical and physi-
ological conditions that might influence patients’ prognosis
[11].
With the increasing prevalence of obesity [12–18], there
is growing evidence that obese patients with SAP might
have worse outcomes in comparison to patients with
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normal body mass index (BMI) [19–24]. The higher mor-
tality of obese patients is thought to be due to the additive
effect of more extensive fat necrosis [25], chronic
up-regulation of the inflammatory response [26], and sub-
sequent increased risk of multiorgan failure (MOF) and
abdominal compartment syndrome (ACS) [22]. However,
further studies are necessary, because some authors have
failed to confirm these findings and found no differences
between obese and nonobese patients [22, 25–27]. Studies
on clinical outcomes of patients admitted to the ICU for
SAP are scarce, and only a few investigated the role of
obesity in the development of ACS. In addition, there is a
lack of studies to evaluate the performance of scoring
systems to predict the development of ACS in the presence
of SAP.
In view of these limitations, the primary purpose of this
study was to test the null hypothesis for in-hospital mor-
tality and the development of ACS between obese and
nonobese patients affected by SAP and admitted to the
ICU. Secondary goals were: to evaluate the incidence of
ACS, to examine risk factors for ACS, to assess the out-
comes of patients undergoing decompressive laparotomy
(DL), and to investigate the performance of validated
scoring systems (e.g., Ranson, APACHE II, Glasgow-Imrie
Scale, SOFA) and selected patients’ characteristics (e.g.,
age, BMI, gender, number of comorbidities) to predict
ACS and in-hospital mortality.
Patients and methods
Study design
A cohort of patients affected by SAP was retrospectively
identified at the Queen Elizabeth II Health Sciences Centre,
Halifax, Nova Scotia (Canada). All patients admitted to the
ICU between July 1, 2005 and June 30, 2009 were screened
for eligibility according to the study protocol approved by
the local ethics review board (ERB). The International
Classification of Diseases Version 9 (ICD-9) code 577.0
was used to identify patients with SAP from a prospec-
tively maintained electronic database. The diagnosis of AP
was confirmed by threefold elevation of serum amylase and
lipase levels during the 72 h period preceding their
admission to the ICU. For each patient, the following
variables were collected: age, gender, body weight, height,
number of comorbidities (ICD-9 codes), date of admission
and discharge from ICU, development of ACS, intra-
abdominal pressures measured in patients with suspected
IAH, need for DL, time interval from diagnosis of ACS to
DL, surgical technique used to manage the laparostomy
site, postoperative abdominal wall complications, and
overall mortality rate.
Severity of AP at the time of ICU admission
was determined by validated prognostic models: Acute
Physiology and Chronic Health Evaluation II score
(APACHE-II; range 0–67) [28, 29], Glasgow Scale (GS;
range 0–8), Sepsis-related Organ Failure Assessment
score (SOFA; range 0–24) [8], Ranson score (range 0–11)
[5, 30], and Charlson Comorbidity Index (CCI) (range
0–36) [31, 32]. Predicted mortality of the study popula-
tion was calculated by using normograms or validated
logistic equations of both Ranson criteria and APACHE-II
scores [33, 34].
Sample size calculation
Sample size calculation was based on the estimated ICU
mortality of nonobese patients that in previous studies was
reported to be up to 30 % [1–3]. The expected mortality of
obese patients was estimated by doubling the death rate of
normal weight individuals affected by SAP as published in
a recent meta-analysis [21]. Using these premises, a total
number of 42 subjects were needed to reach a power of 0.8
with a two-tail alpha level of 0.05.
Inclusion and exclusion criteria
Patients included in this study satisfied the following cri-
teria: adult age (older than 18 years), a primary diagnosis
of SAP by the Atlanta criteria [35, 36] and requiring
admission to ICU for at least one of the following condi-
tions: hypotension, renal failure, respiratory insufficiency,
cardiac dysfunction, disseminated intravascular coagula-
tion, or gastrointestinal hemorrhage [37].
Exclusion criteria were: pregnant women, patients
younger than 18 years, diagnosis of acute or chronic pan-
creatitis, recent traumas, or surgical interventions respon-
sible for the development of AP.
Definitions
Severity of acute pancreatitis
SAP was defined as AP in the context of new onset of
organ failure and/or local complications according to the
revised Atlanta classification of AP [35, 36] _ENREF_37.
Patients with SAP were defined as affected by at least one
organ failure that lasted more than 48 h or who developed
complications leading to death.
On the first day of admission to ICU, the severity of AP
was measured by utilizing the Glasgow-Imrie score [6], the
APACHE II [7], and the SOFA [8] scores. A fourth
prognostic model, the Ranson score [5], was calculated by
the combination of patients’ age, laboratory, and clinical
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variables obtained at the time of hospital admission and
48 h later. Predicted mortality rate of the study population
was calculated by using the Ranson score and the adjusted
APACHE II logistic regression model [34]:
Predicted death rate ¼ 3; 517 þ APACHE II scoreð Þ
 0:146 þ 0:501:
Calculations were performed by accessing the on line
calculator available at the Societe’ Francoise d’Anesthesie
et de Ranimation webpage [38].
Abdominal compartment syndrome
Abdominal compartment syndrome was defined as the
presence of intra-abdominal pressure equal or higher than
20 mmHg in association with acute organ failure [39].
Intraperitoneal pressure was measured by inserting a
standard Foley urinary catheter of at least 16 Fr into the
patient’s bladder, which was then filled with 25–30 mL of
saline solution. Measurements of the intra-abdominal
pressure were obtained at the end of the expiration and with
the patients in supine position [40] by connecting the Foley
catheter to a digital pressure transducer after clamping its
outflow channel. The pubic symphysis was considered the
reference level [41].
Alternatively, ACS was diagnosed during clinical
examinations when patients experienced severe abdominal
distension and at least one of these other conditions: (1)
tachycardia and/or hypotension despite elevation of the
central venous pressure (CVP), (2) tachypnea and/or ele-
vated peak inspiratory pressures when on ventilator support
with refractory hypoxemia and/or hypercapnia, (3) renal
dysfunction not responsive to intravenous diuretics or
dopamine infusion [40].
Obesity
Body mass index (BMI; Kg/m2) C30 was used as a cutoff
point to identify obese patients according to the definition
proposed by the World Health Organization [11].
Decompressive laparotomy
Decompressive laparotomy was defined as any surgical
intervention designed to reinstitute the physiological
abdominal wall compliance. This was obtained by inter-
rupting the skin, fascia, and peritoneum along a midline
abdominal incision extending from the xiphoid process of
the sternum to the suprapubic area in combination with the
anterior wall muscles if necessary [42]. During DL, the
intra-abdominal organs were inspected and released from
the tension of the enclosed cavity until a satisfactory
cardiopulmonary response was obtained. All patients
underwent exposure of edematous intestinal loops, omen-
tum, and solid organs, and none was treated by subcuta-
neous linea alba fasciotomy or transverse laparostomy [40,
43, 44]. Intraperitoneal drains were placed at the discretion
of the surgeons and no pancreatic debridement was per-
formed during DL.
Temporary abdominal closure
Temporary abdominal closure was defined as any technique
used to close the abdominal cavity provisionally by creating
a laparostomy that allowed decompression of the intra-
peritoneal organs but preventing their contamination,
hypothermia, and fluid losses [45]. Available techniques for
the provisional abdominal wall closure were: (1) placement
of absorbable mesh material consisting of polyglactin 910
(Vicrlyl-mesh, Ethicon) or polyglicolic acid (Dexon-
mesh, Dexon) [46, 47], (2) coverage of the intra-abdom-
inal organs with expanded polytetrafluoroethylene (ePTFE)
foils [48, 49] or adhesive (Opsite plastic dressing, 3 M,
Tegaderm) and nonadhesive plastic layer derived from
irrigation bags (e.g., Bogota-bag) [49, 50], and (3) com-
bining adhesive plastic foils with a polygalactin sponge
(V.A.C KCL) and delivering a constant negative pressure
of 100–150 mmHg applied via tubes connected to a com-
puterized portable vacuum device [51–53].
Length of hospital stay and mortality
Hospital stay was defined as the number of days that each
patient spent at the tertiary medical centre. All causes of
mortality during this period of time were considered direct
consequences of SAP. Deaths that might have occurred
after the patients were discharged home or to rehabilitation
centers or to long-term facilities were not measured as not
traceable by the investigators.
Statistical analysis
Summary statistics were constructed for the baseline val-
ues, using frequencies and proportions for categorical data,
and mean and standard deviation (SD) for continuous
variables. Categorical outcomes were analyzed by using
chi-square test or Fisher’s exact test when appropriate.
Continuous variables were compared by using Mann–
Whitney or Kruskal–Wallis test. Univariate logistic anal-
ysis also was preformed to look for possible associations
with morbidity, mortality, and the development of ACS
(age, obesity, number of comorbidities, Ranson score,
SOFA score, Glasgow-Imrie score, APACHE II score).
Multivariable logistic regression analyses were performed
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using step-wise techniques to explore predicting factors for
the development of ACS and mortality. The stepwise
procedure was set at the threshold of 0.1 for inclusion and
0.05 for exclusion. Discrimination was analyzed as the
capacity of prognostic models or clinical parameters to
distinguish high-risk from low-risk individuals for hospital
mortality and development of ACS. Discrimination of
predicting factors was then assessed by Receiver Operating
Characteristic (ROC) curves. Excellent discrimination
was defined if the area under the curve (AUC) of ROC was
C0.8, good discrimination was defined when the AUC was
between 0.7 and 0.8 and poor discrimination when the
AUC was \0.7. ROC curves were compared to the refer-
ence line associated with AUC = 0.5. Statistical analysis
was performed by using SPSS software (Version 19,
SPSS, Inc., Chicago, IL), and all tests were two-tailed and
considered significant when P \ 0.05.
Results
Study cohort
During a 4-year period, a total of 72 patients were admitted
to ICU with the diagnosis of AP. After reviewing their
medical files, 27 subjects were excluded, because they
failed to satisfy the revised Atlanta criteria for SAP pub-
lished in 2008 [35, 36] as their organ failure resolved
within 48 h. The remaining 45 patients represented the
study population and their demographic and clinical char-
acteristics are summarized in Table 1. Mean time from
hospital admission to ICU admission was 3.8 days.
Obesity, morbidity, mortality, and decompressive
laparotomy
Obesity was observed in 24 (53 %) patients who had
clinical presentation, disease severity, and demographic
characteristics similar to patients with lower BMI but sig-
nificantly lower in-hospital mortality: 12.5 versus 38 %
(P = 0.04; Table 2). Urgent DL was performed in 41 % of
obese patients, whereas in only 28 % of nonobese patients
(P = 0.533). Obese patients who underwent DL had sim-
ilar clinical presentation and overall outcomes to nonobese
individuals except that they experienced more postopera-
tive incisional hernias (70 vs. 16 %; P = 0.039; Table 3).
In-hospital mortality
Among all 45 patients, 11 (24.4 %) died from complica-
tions of SAP (Table 4). Univariate analysis showed that
mortality was associated with older age (P = 0.001), lower
systolic blood pressure at admission to ICU (P = 0.05),
and higher number of comorbidities (P = 0.001). Predicted
mortality by Ranson criteria and by APACHE II score for
the entire cohort were 41 % (SD = 30.2) and 38.3 %
(SD = 19.4), respectively. Comparison between observed
(24 %) and predicted (38–41 %) mortality by APACHE II
Score of the entire cohort was clinically but not statistically
significant (P = 0.175).
Univariate logistic regression analysis showed that age
was a significant predictor of in-hospital mortality for the
entire cohort (odds ratio (OR) 1.159; 95 % CI = 1.043–
1.288; P = 0.006) and more so for obese patients (OR 1.191;
95 % CI = 1.012–1.401; P = 0.035; Table 5). After
adjusting for the severity of the disease by Ranson, SOFA,
APACHE II and Glasgow-Imrie scores, obesity status, and
development of ACS, the only significant predictor for in-
hospital mortality in the study population was patients’ age
(OR 1.273; 95 % CI = 1.052–1.541; P = 0.013).
Receiver operator characteristic (ROC) curves for
in-hospital mortality for ICU patients with SAP showed
that both age and the number of comorbidities had excel-
lent discrimination with AUC measuring 0.846 (95 % CI =
0.7–0.99; P = 0.001) and 0.801 (95 % CI = 0.633–0.968;
P = 0.003), respectively (Fig. 1). On the other hand,
established predictive models (Ranson, Glasgow-Imrie,
SOFA, APACHE II) had low discrimination with AUC
ranging from 0.5 (APACHE II) to 0.584 (Ranson).
Risk factors for abdominal compartment syndrome
and outcomes of decompressive laparotomy
Analysis of the clinical and laboratory characteristics of
patient who developed ACS and underwent DL revealed
that they were more frequently males (P = 0.03), had a
higher respiratory and heart rate (P = 0.008, 0.01), lower
systolic blood pressure (P = 0.05), and higher serum cre-
atinine levels (P = 0.04) at admission to ICU than patients
who did not develop ACS (Table 6). Univariate logistic
regression analysis found that only serum creatinine was
associated with higher probability of developing ACS (OR
1.115; 95 % CI = 1.02–1.219; P = 0.017; Table 7). At
multivariable regression analysis, after adjusting for the
severity of the disease (Ranson, SOFA, APACHE II,
Glasgow-Imrie Scores), age, and presence of obesity, only
Glasgow-Imrie and APACHE II scores were significant
predictors for ACS with OR of 1.221 and 1.143, respec-
tively (Glasgow-Imrie 95 % CI = 1.000–1.493; P = 0.05)
(APACHE II 95 % CI = 1.012–1.292; P = 0.032).
Hospital stay for patients who underwent DL was sig-
nificantly longer (146 vs. 60 days; P = 0.001) compared
with patients who did not develop ACS, but they did not
experience higher mortality rates (25 vs. 24 %; P = 0.9).
All 16 patients who underwent DL had a temporary
abdominal wall closure with either Bogota bag (11
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subjects) or wound V.A.C system (five subjects). Delayed
primary closure was performed in 11 patients and split-
thickness skin graft was necessary in five. Perioperative
complications of DL were significant with ten surgical site
infections that ultimately led to eight hernias requiring
delayed repair, seven entero-atmospheric fistulas that
were managed by late intestinal resections, three wound
dehiscences that were fixed surgically, and three pancrea-
tico-atmospheric fistulas that resolved without any further
surgical intervention.
ROC curves for the development of ACS showed that there
were no clinical or laboratory characteristics with acceptable
discrimination (Fig. 2). Serum creatinine level at admission to
ICU and respiratory rate had better discrimination perfor-
mance with AUC equal to 0.69 and 0.68, respectively, com-
pared with established prognostic models with AUC ranging
from 0.58 (Ranson) to 0.66 (APACHE II). Presence of obesity
had poor discrimination with AUC = 0.57.
Discussion
Obesity, mortality, development of abdominal
compartment syndrome and decompressive laparotomy
To our knowledge, this is the first study to compare the
outcomes of obese patients admitted to the ICU with SAP
versus nonobese individuals. Other authors published out-
comes from retrospective cohorts of all patients affected by
AP and did not restrict their analysis to those requiring ICU
care for SAP [19–21, 26, 54–59]. Our study has shown that,
in these settings, obesity might be protective for mortality
but not for the development of ACS. Because obese patients
underwent DL more often than nonobese individuals, their
lower mortality is quite provocative, because it seems to
conflict with previous studies [19–21, 24, 26, 54–59].
Lankisch et al. [60] were the first to report higher risk of
respiratory, renal, and circulatory insufficiency in patients
with elevated body weight affected by AP. Several other
small studies have subsequently reported a positive corre-
lation between obesity and respiratory failure, local com-
plications, and death [20, 54, 55]. A recent meta-analysis
found a twofold increase in mortality in obese patients with
AP [21]. The mechanisms by which obesity adversely
affects the course of AP are still unclear [24, 56]. Over-
weight patients have an up-regulated systemic [53, 54, 58, 61]
and local inflammatory response [24, 52, 57, 62]. They are
more frequently immunodeficient [61, 62] and have larger
deposits of retroperitoneal and visceral fat where necrosis and
infections frequently occur in AP [24, 52, 63, 64]. Their
pancreatic microcirculation is to some extent compromised
by fat deposition in the gland, and the pancreas therefore is
Table 1 Patients’ characteristics and clinical variables at admission




Age, year (mean, SD) 59 (13.3)
Male gender (no. patients, %) 36 (80)
Hospital mortality (no. patients, %) 11 (24.4)
Length of overall hospital stay, days (mean, SD) 85.9 (107.8)




Postendoscopic cholangiopancreatography (ERCP) 2 (4.4)
Clinical variables at admission to ICU
BMI (mean, SD) 30.6 (5.2)
Obesity (BMI [ 30) (no. patients, %) 24 (53)
Body temperature, Celsius (mean, SD) 37.8 (0.7)
Heart rate/min (mean, SD) 111.5 (19.3)
Systolic blood pressure, mmHg (mean, SD) 128.4 (20.1)
Diastolic blood pressure, mmHg (mean, SD) 68.2 (13.6)
Respiratory rate/min (mean, SD) 19.7 (8.9)
Laboratory variables at admission to ICU
White blood cells, 103/lL (mean, SD) 14.9 (4.5)
Platelets, 103/lL (mean, SD) 221.4 (139)
Creatinine, lmol/L (mean, SD) 217.7 (160)
Glucose, mmol/L (mean, SD) 8.9 (4.4)
LDH, U/L (mean, SD) 479.3 (335.8)
AST, U/L (mean, SD) 90.4 (74.3)
Arterial pH (mean, SD) 7.3 (0.1)
Alveolar arterial gradient (A-a gradient) (mean, SD) 288.2 (164.3)
Pulmonary artery oxygen/FiO2 ratio (mean, SD) 182.5 (82.2)
Laboratory variables at 48 h after admission to ICU
Serum calcium, mmol/L (mean, SD) 2.1 (0.1)
Blood urea nitrogen, mmol/L (mean, SD) 13.6 (8.3)
Sequestration of more than 6 L in 48 h (no.
patients, %)
44 (97.8)
Blood urea nitrogen increase at least by 1.8 (no.
patients, %)
26 (59.1)
PaO2 \60 mmHg within 48 h (no. patients, %) 12 (26.7)
Hematocrit fall [10 % (no. patients, %) 43 (95)
CCI at admission to ICU (mean, SD) 2.8 (2)
Severity of acute pancreatitis at admission to ICU
Ranson score (mean, SD) 5.4 (1.7)
Glasgow-Imrie scale (mean, SD) 9.1 (4)
APACHE II score (mean, SD) 20.3 (6.4)
Sequential Organ Failure Assessment (mean, SD) 8.5 (3)
Abdominal compartment syndrome (no. patients, %) 16 (35.5)
ERCP endoscopic retrograde cholangiopancreatography, BMI body
mass index, LDH lactic dehydrogenase, AST aspartate transaminase,
CCI Charlson Comorbidity Index
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Table 2 Characteristics of










Variable BMI C 30 (n = 24) BMI \ 30 (n = 21) P value
Demographic
Age, year (mean, SD) 58.5 (13.9) 60.4 (12.8) 0.063
Male gender (no. patients, %) 19 (79.1) 17 (80.1) 0.88
Hospital mortality (no. patients, %) 3 (12.5) 8 (38.0) 0.046
Length of overall hospital stay, days (mean, SD) 110.7 (136.8) 57.7 (49.8) 0.087
Etiology of pancreatitis (no. patients, %)
Gallstone 12 (50.0) 12 (57.1) 0.218
Alcohol 8 (33.3) 4 (19.0)




Use of parenteral antibiotics for prophylaxis
(no. patients, %)
22 (91.6) 17 (80.9) 0.396
Clinical variables at admission to ICU
BMI (mean, SD) 34.1 (4.3) 26.6 (2.5) 0.0001
Body temperature, Celsius (mean, SD) 37.9 (0.77) 37.6 (0.76) 0.168
Heart rate/min (mean, SD) 108.1 (20.2) 115.4 (17.9) 0.209
Systolic blood pressure, mmHg (mean, SD) 128.0 (17.0) 129.0 (23.8) 0.869
Diastolic blood pressure, mmHg, (mean, SD) 67.2 (12.5) 69.5 (15.1) 0.583
Respiratory rate/min (mean, SD) 19.8 (8.3) 19.7 (9.7) 0.965
Laboratory variables at admission to ICU
White blood cells, 103/lL (mean, SD) 15.1 (4.9) 14.7 (4.1) 0.327
Platelets, 103/lL (mean, SD) 228.6 (177.3) 213.1 (78.6) 0.715
Creatinine, lmol/L (mean, SD) 249.6 (169.5) 181.2 (143.7) 0.155
Glucose (mmol/L) (mean, SD) 8.8 (3.4) 9.0 (5.3) 0.882
LDH, U/L (mean, SD) 521.5 (400.4) 431.1 (243.0) 0.373
AST, U/L (mean, SD) 100.3 (86.9) 79.2 (56.5) 0.348
Arterial pH (mean, SD) 7.31 (0.08) 7.35 (0.11) 0.223
Alveolar arterial gradient (A-a gradient),
(mean, SD)
313.11 (180.1) 260.0 (143.1) 0.285
Pulmonary artery oxygen/FiO2 ratio (mean, SD) 111.5 (52.9) 95.8 (58.4) 0.35
Laboratory variables at 48 h after admission to ICU
Serum calcium (mmol/L) (mean, SD) 2.1 (0.2) 2.1 (0.1) 0.836
Blood urea nitrogen (mmol/L) (mean, SD) 15.2 (9.4) 12.0 (6.6) 0.205
Sequestration of more than 6 L in 48 h
(no. patients, %)
24 (100) 20 (95.2) 0.28
Blood urea nitrogen increase at least by 1.8
(no. patients, %)
15 (62.5) 11 (52.3) 0.387
PaO2 \60 mmHg within 48 h (no. patients, %) 6 (25) 6 (28.5) 0.787
Hematocrit fall [10 % (no. patients, %) 23 (95.8) 20 (95.2) 0.923
CCI at admission to ICU (mean, SD) 2.7 (1.9) 3.0 (2.1) 0.531
Severity of acute pancreatitis at admission to ICU
Ranson score system 5.6 (1.9) 5.1 (1.5) 0.373
Glasgow scale 8.1 (4.6) 10.1 (3.0) 0.098
APACHE II score (mean, SD) 22.0 (7.0) 18.3 (5.0) 0.053
Sequential Organ Failure Assessment (mean, SD) 9.3 (3.3) 7.6 (2.5) 0.067
Decompressive laparotomy (no. patient, %) 10 (41.6) 6 (28.5) 0.533
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chalmore prone to necrosis [26]. Excessive body weight also
reduces the compliance of the chest wall, diaphragm, and
abdominal wall with subsequent increased thoracic and per-
itoneal pressures [26]. The negative prognostic factor repre-
sented by obesity is therefore supported by both biological
and clinical observations [24]. However, there is still con-
troversy on this topic [1, 2] as the evidence that obese patients
experience worse outcome [19, 21, 54–56] has been lenged
by several more recent large clinical studies [22, 25, 59].
Mery et al. [61] have shown that the distribution of fat in the
body might be more important than obesity itself for the
modulation of SIRS and the risk of mortality in AP. Recent
experimental data suggested that visceral fat produces
more inflammatory mediators than subcutaneous fat [62],
and a clinical study has found that only increased visceral
fat distribution was a negative predictor of survival in AP
[61].
Prediction of mortality
In our cohort, the observed mortality was 24 % and not
significantly different from other studies that reported a
range between 17 and 39 % [65–67]. Compared with the
predicted mortality by Ranson and the APACHE II scores,
the observed death rate was much lower, although it did not
reach statistical significance. There are many possible rea-
sons for the discrepancy between predicted and observed
mortality in this study. During the past few decades, sig-
nificant improvements occurred in the management of MOF
patients with SAP [1], including the introduction of paren-
teral and enteral nutrition and more effective broad-spec-
trum antibiotics [1, 68]. Surgeons also have played an
important role in improving the overall outcomes of patients
with SAP by being more selective when recommending
surgery and by using less invasive procedures for the
debridement of necrotic tissue [1, 63]. As a result, a growing
proportion of patients with SAP is now able to overcome
both the early systemic inflammatory response syndrome
(SIRS) and the second phase of illness characterized by
sepsis and organ failure [57, 64, 69–71]. Because of these
important changes in the management of patients with SAP,
it might be necessary to reevaluate the role of predicting
models that were introduced several decades ago [5–9, 23,
24, 28–30, 32, 65, 66, 72]. In our study, advanced age and the
presence of comorbidities seemed to play a more influential
role than any of the well recognized predicting models.
Contrary to the results reported by Ueda et al. [67] who
observed that both Ranson and APACHE II scores had good
discrimination for mortality with AUC of 0.8, our findings
supported the results of other authors [58, 68, 73], who
observed that Ranson score was a relatively poor predictor
for in-hospital mortality, whereas age and the presence of
comorbidities were better discriminating factors. While the
limited sample size may account for some variations, it also
Table 3 Summary of clinical
characteristics, early and late
management of the open
abdomen after decompressive
laparotomy in obese









Intra-abdominal pressure, mmHg (bladder pressure
measurement, mean, SD)
26.7 (9.3) 32.3 (15.2) 0.361
Patients with bladder pressure C20 mmHg (no. patients, %) 8 (80) 5 (83.3) 0.482
Clinical presentation of ACS (no. patients, %)
Abdominal distension with acute renal failure 4 (40) 1 (16.6) 0.588
Abdominal distension with acute respiratory failure 6 (60) 5 (83.3)
Time between diagnosis of ACS and surgical
decompression, hr (mean, SD)
3.3 (1.7) 2.8 (1.7) 0.638
Early management of abdominal incision (no. patients, %)
Bogota bag 7 (70) 4 (66.6) 0.889
Wound VAC system 3 (30) 2 (33.3)
Late management of abdominal incision (no. patients, %)
Delayed primary abdominal wall closure 6 (60) 5 (83.3) 0.33
Use of split-thickness skin graft 3 (30) 0 0.137
Death before abdominal incision closure 1 (10) 1 (16.6) 0.761
Abdominal complication after decompressive laparotomy (no. patients, %)
Pancreatico-cutaneous fistula 1 (10) 2 (33.3) 0.247
Entero-cutaneous / entero-atmospheric fistula 5 (50) 2 (33.3) 0.515
Incisional infection 8 (80) 2 (33.3) 0.062
Wound dehiscence 3 (30) 0 0.137
Incisional hernia 7 (70) 1 (16.6) 0.039
In-hospital mortality (no. patients, %) 1 (10) 2 (33.3) 0.252
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Table 4 Characteristics of patients who died versus patients who survived severe acute pancreatitis
Variable Patients who died (n = 11) Patients who survived (n = 34) P value
Demographic
Age, year (mean, SD) 70.9 (11.9) 55.7 (11.6) 0.001
Male gender (no. patients, %) 9 (81.8) 27 (79.4) 0.78
Etiology of pancreatitis (no. patients, %)
Gallstone 9 (81.8) 15 (44.1) 0.176
Alcohol 1 (9) 11 (32.3)
Idiopathic 1 (9) 6 (17.6)
Postendoscopic cholangiopancreatography (ERCP) 0 2 (5.8)
Length of overall hospital stay, days (mean, SD) 25 (21.9) 105.7 (117.1) 0.017
Clinical variables on admission to ICU
BMI (mean, SD) 28.6 (3.1) 31.2 (5.6) 0.128
Obesity (BMI [ 30) (no. patients, %) 3 (27.2) 21 (61.7) 0.08
Body temperature, Celsius (mean, SD) 37.5 (0.7) 37.8 (0.7) 0.199
Heart rate/min (mean, SD) 112.0 (19.2) 111.4 (19.6) 0.921
Systolic blood pressure, mmHg (mean, SD) 117.6 (19.3) 131.8 (19.4) 0.05
Diastolic blood pressure, mmHg (mean, SD) 64.7 (9) 69.4 (14.7) 0.348
Respiratory rate/min (mean, SD) 20.7 (10.6) 19.4 (8) 0.68
Bladder pressure measurement, mmHg (mean, SD) 22.7 (5.1) 30.8 (12.7) 0.24
Laboratory variables on admission to ICU
White blood cells, 103/lL (mean, SD) 13.7 (3.7) 15.3 (4.7) 0.31
Platelets, 103/lL (mean, SD) 217.5 (80.1) 222.6 (154.2) 0.91
Creatinine, lmol/L (mean, SD) 211.0 (126.4) 219.9 (171) 0.87
Glucose, mmol/L (mean, SD) 11.0 (6.9) 8.3 (3) 0.069
LDH, U/L (mean, SD) 326.3 (113.4) 528.8 (368.9) 0.082
AST, U/L (mean, SD) 67.2 (34.8) 98.0 (82.1) 0.237
Arterial pH (mean, SD) 7.30 (0.92) 7.34 (0.1) 0.354
Alveolar arterial gradient (A-a gradient) (mean, SD) 261.1 (105.3) 297.1 (179.7) 0.531
Pulmonary artery oxygen/FiO2 ratio (mean, SD) 117.7 (58.9) 99.7 (54.5) 0.357
Laboratory variables at 48 h after admission to ICU
Serum calcium, mmol/L (mean, SD) 2.1 (0.2) 2.1 (0,.17) 0.64
Blood urea nitrogen, mmol/L (mean, SD) 12.5 (2.4) 14.0 (9.3) 0.641
Sequestration of more than 6 L in 48 h (no. patients, %) 11 (100) 33 (97) 1
Blood urea nitrogen increase at least by 1.8 (no. patients, %) 7 (63.6) 19 (55.8) 0.489
PaO2 \60 mmHg within 48 h (no. patients, %) 3 (27.2) 9 (26.4) 1
Hematocrit fall [10 % (no. patients, %) 3 (27.2) 9 (26.4) 1
CCI at admission to ICU (mean, SD) 2.3 (1.7) 4.5 (2) 0.001
Severity of acute pancreatitis on admission to ICU
Ranson score system 5.63 (1.9) 5.38 (1.9) 0.683
Glasgow scale 10.1 (1.9) 8.7 (4.5) 0.324
APACHE II score (mean, SD) 20.6 (4.6) 20.2 (6.9) 0.87
Sequential Organ Failure Assessment (mean, SD) 8.6 (2.2) 8.5 (3.3) 0.921
Decompressive laparotomy (no. patients, %) 4 (36.3) 12 (35.2) 1.00
Early management of abdominal incision (no. patients, %)
Bogota bag 2 (18.1) 9 (26.4) 0.547
Wound VAC system 2 (18.1) 3 (8.8)
Late management of abdominal incision (no. patients, %)
Delayed primary abdominal wall closure 3 (27.2) 8 (23.5) 1
Use of split-thickness skin graft 0 3 (8.8) 0.529
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Table 5 Univariate logistic regression: risk factors for in-hospital mortality
Variable OR for entire study population
(95 % CI)
P value OR for obese patients
(95 % CI)
P value OR for nonobese patients
(95% CI)
P value
Age (year) 1.159 (1.043, 1.288) 0.006 1.191 (1.012, 1.401) 0.035 1.134 (0.99, 1.298) 0.069
Systolic blood pressure
(mmHg)
0.956 (0.913, 1.002) 0.058 0.966 (0.895, 1.044) 0.966 0.051 (0.896, 1.01) 0.103
Obesity (BMI [ 30) 4.308 (0.965, 19.236) 0.056 – – – –
Abdominal compartment
syndrome
0.955 (0.232, 3.932) 0.949 – – – –
Charlson Comorbidity score 1.845 (1.199, 2.84) 0.005 3.782 (1.06, 13.489) 0.04 1.518 (0.929, 2.483) 0.096
Ranson score 1.085 (0.749, 1.591) 0.676 0.789 (0.376, 1.654) 0.53 1.761 (0.872, 3.555) 0.114
SOFA score 1.012 (0.808, 1.267) 0.318 1.164 (0.782, 1.733) 0.454 1.057 (0.739, 1.513) 0.761
APACHE II score 1.009 (0.907, 1.124) 0.866 1.06 (0.875, 1.283) 0.553 1.061 (0.882, 1.277) 0.529
Glasgow-Imrie score 1.095 (0.917, 1.307) 0.919 1.106 (0.842, 1.453) 0.47 1.011 (0.75, 1.362) 0.942
Bold indicate statistical significant values
Table 4 continued
Variable Patients who died (n = 11) Patients who survived (n = 34) P value
Complication after abdominal wall closure
(no. patients, %)
Pancreatico-cutaneous fistula 0 3 (8.8) 0.529
Entero-cutaneous fistula 1 (9.0) 6 (17.6) 0.585
Incisional infection 1 9 (26.4) 0.118
Wound dehiscence 1 2 (5.8) 1
Incisional hernia 1 7 (20.5) 0.569
Bold indicate statistical significant values
ERCP endoscopic retrograde cholangiopancreatography, BMI body mass index, LDH lactic dehydrogenase, AST aspartate transaminase,
ICU intensive care unit, CCI Charlson Comorbidity Index
Fig. 1 Receiver operating characteristic (ROC) curves for hospital
mortality of patients affected by severe acute pancreatitis (SAP). Area
under the curve (AUC) for discriminating variables at the time of
patients’ admission to the intensive care unit (ICU). a Patients’
age = 0.846 (95 % confidence interval (CI) = 0.7–0.99; P = 0.001),
b Charlson Comorbidity Score = 0.801 (95 % CI = 0.633–0.968;
P = 0.003), c Ranson criteria = 0.584 (95 % CI = 0.415–0.753;
P = 0.405), d Glasgow Coma Scale = 0.56 (95 % CI = 0.394–0.726;
P = 0.552), e Sequential Organ Failure Assessment Score
(SOFA) = 0.537 (95 % CI = 0.363–0.712; P = 0.712), f Acute Phys-
iologic and Chronic Health Evaluation (APACHE) II score = 0.509
(95 % CI = 0.334–0.684; P = 0.926) (All P values are calculated for
each variable in comparison to the reference line; AUC = 0.5)
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Age, year (mean, SD) 55.9 (12.9) 60.7 (14) 0.39
Male gender (no. patients, %) 16 (100) 20 (68.9) 0.03
Etiology of pancreatitis (no. patients, %)
Gallstone 7 (43.8) 17 (58.6) 0.22
Alcohol 7 (43.8) 6 (20.6)
Idiopathic 2 (12.5) 5 (17.2)
Postendoscopic Cholangiopancreatography (ERCP) 0 2 (6.8)
Length of overall hospital stay, days (mean, SD) 146.2 (148.5) 60.9 (65.2) 0.001
Clinical variables at admission to ICU
BMI (mean, SD) 30.3 (3.7) 30.8 (5.8) 0.66
Obesity (BMI [ 30) (no. patients, %) 10 (62.5) 15 (51.7) 0.48
Body temperature, Celsius (mean, SD) 37.7 (0.8) 37.8 (0.7) 0.82
Heart rate/min (mean, SD) 122.5 (14.3) 107.1 (19.4) 0.01
Systolic blood pressure, mmHg (mean, SD) 119.4 (21.3) 132.5 (18.5) 0.05
Diastolic blood pressure, mmHg (mean, SD) 65.4 (15.9) 69.5 (12.5) 0.37
Respiratory rate/min (mean, SD) 27.0 (11.4) 16.8 (5.4) 0.008
Laboratory variables at admission to ICU
White blood cells, 103/lL (mean, SD) 17.7 (5.1) 13.8 (5) 0.29
Platelets, 103/lL (mean, SD) 187.3 (90.6) 235.2 (153.4) 0.29
Creatinine, lmol/L (mean, SD) 292.6 (196.3) 187.2 (134.5) 0.04
Glucose, mmol/L (mean, SD) 10.7 (3.5) 8.2 (4.5) 0.08
LDH, U/L (mean, SD) 485.0 (348.2) 477 (336.3) 0.94
AST, U/L (mean, SD) 73.2 (36.6) 97.5 (84.5) 0.32
Arterial pH (mean, SD) 7.2 (0.9) 7.3 (0.1) 0.11
Alveolar arterial gradient (A-a gradient) (mean, SD) 346.2 (167.2) 264.8 (159.7) 0.13
Pulmonary artery oxygen/FiO2 ratio (mean, SD) 91.3 (25.5) 109.3 (63.4) 0.33
Laboratory variables at 48 h after admission to ICU
Serum calcium, mmol/L (mean, SD) 2.1 (0.1) 2.2 (0.1) 0.2
Blood urea nitrogen, mmol/L (mean, SD) 13.5 (8.3) 13.7 (8.4) 0.95
Sequestration of more than 6 L in 48 h (no. patients, %) 16 (100) 28 (96.5) 0.51
Blood urea nitrogen increase at least by 1.8
(no. patients, %)
9 (56.2) 17 (58.6) 0.74
PaO2 \60 mmHg within 48 h (no. patients, %) 4 (25) 9 (31) 0.46
Hematocrit fall [10 % (no. patients, %) 16 (100) 26 (89.6) 0.3
CCI at admission to ICU (mean, SD) 2 (1.6) 3.2 (2) 0.06
Severity of acute pancreatitis at admission to ICU
Ranson score system 6 (1.8) 5.2 (1.6) 0.18
Glasgow scale 9.9 (4.7) 8.7 (4.6) 0.4
APACHE II score (mean, SD) 22.6 (6.2) 19.4 (6.3) 0.13
Sequential Organ Failure Assessment (mean, SD) 9 (2.9) 8.3 (3.1) 0.47
Time interval between diagnosis of ACS and DL
(h) (mean, SD)
3.1 (1.7) n.a. –
In-hospital mortality (no. patients, %) 4 (25) 7 (24.1) 0.9
Bold indicate statistical significant values
ERCP endoscopic retrograde cholangiopancreatography, BMI body mass index, LDH lactic dehydrogenase, AST aspartate transaminase,
ICU intensive care unit, DL decompressive laparotomy, ACS abdominal compartment syndrome, n.a. not applicable
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is possible that different inclusion criteria might have played
an important role as other studies did not include only sub-
jects affected by SAP and requiring ICU admission [69].
Prediction of abdominal compartment syndrome
ACS was observed in 35 % of this cohort, similarly to pre-
vious studies where 23 [74] and 56 % [75] of patients with
SAP developed IAH. The clinical relevance of ACS is
illustrated by the significantly longer hospital stay compared
with those who did not require DL as previously described by
Al-Bahrani et al. [75]. Contrary to our experience, De Waele
et al. [76] not only reported significantly longer ICU and
hospital stays in patients with IAH but also an increased
mortality. In our study, the mortality rate of patients who
developed ACS was 25 %, similar to that observed in
patients who did not develop IAH. This might be due to the
fact that patients who underwent DL at our institution were
Table 7 Univariate logistic regression: risk factors for abdominal compartment syndrome
Variable OR for entire study population
(95 % Cl)
P value OR for obese patients
(95% CI)





1.115 (1.02, 1.219) 0.017 1.005 (0.999, 1.01) 0.103 1.003 (0.996, 1.009) 0.412
Respiratory Rate/
minute
1.004 (1, 1.008) 0.053 1.071 (0.961, 1.193) 0.213 1.206 (0.997, 1.46) 0.054
Age 0.968 (0.922, 1.017) 0.195 0.961 (0.899, 1.028) 0.249 0.981 (0.911, 1.055) 0.597
Obesity (BMI [ 30) 0.56 (0.161, 1.949) 0.362 – – – –
Charlson
Comorbidity score
0.79 (0.568, 1.099) 0.162 0.951 (0.622, 1.453) 0.816 0.603 (0.327, 1.114) 0.106
Ranson score 1.13 (0.798, 1.601) 0.49 1.166 (0.763, 1.783) 0.478 0.985 (0.516, 1.878) 0.963
SOFA score 1.079 (0.88, 1.322) 0.465 1.062 (0.825, 1.369) 0.64 1.039 (0.708, 1.525) 0.844
APACHE II score 1.085 (0.978, 1.204) 0.122 1.05 (0.929, 1.185) 0.436 1.163 (0.924, 1.464) 0.197
Glasgow-Imrie score 1.064 (0.911, 1.241) 0.434 1.148 (0.95, 1.388) 0.152 0.92 (0.667, 1.268) 0.61
Bold indicate statistical significant values
Fig. 2 Receiver operating characteristic (ROC) curves for the develop-
ment of abdominal compartment syndrome (ACS) in patients affected by
severe acute pancreatitis (SAP). Area under the curve (AUC) for
discriminating variables at the time of patients’ admission to the intensive
care unit (ICU), a Serum creatinine = 0.699 (95 % CI = 0.54–0.858;
P = 0.028), b Respiratory rate = 0.681 (95 % CI = 0.515–0.847;
P = 0.046), c Acute Physiologic and Chronic Health Evaluation
(APACHE) II score = 0.661 (95 % CI = 0.487–0.835; P = 0.07,
d Glasgow Coma Scale = 0.584 (95 % CI = 0.394–0.774; P = 0.355),
e Sequential Organ Failure Assessment Score (SOFA) = 0.582 (95 %
CI = 0.411–0.753; P = 0.368), f Obesity (BMI C 30) = 0.571 (95 %
CI = 0.396–0.747; P = 0.434), g Ranson score = 0.548 (95 %
CI = 0.365–0.732; P = 0.594) (All P values are calculated for each
variable in comparison to the reference line; AUC = 0.5)
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taken to the operative room within a very short period as the
median time interval from diagnosis to the start of DL was
only 3.1 h. The rationale to perform an urgent DL was to
restore, as soon as possible, the physiological microcircu-
latory parameters and avoid further damage to the renal and
cardiorespiratory systems [77]. Although this might be valid
for trauma patients, we recognize that there is lack of studies
to support this strategy in AP and it is still unknown the
optimal time for intervention and the optimal threshold of
IAP that would mandate surgical decompression in patients
with SAP [4, 78, 79]. It also is unclear the degree to which
IAH contributes to the progression of organ dysfunction in
patients with SAP and deteriorating organ function. Mentula
et al. [77] found that patients with IAP exceeding 25 mmHg
within the first 4 days after diagnosis of SAP might be good
candidates for surgical decompression, but there is need for
more studies to support these findings.
Outcomes of decompressive laparotomy
Substantial morbidity was associated with DL, and the
decision to perform surgery had important clinical impli-
cations [80]. An open abdomen is a well-recognized risk
factor for the development of fistulas, intra-abdominal
abscesses, abdominal wall infections, and hernias whose
management can be very challenging especially in obese
patients [80]. In this study, enterocutaneous or enteroat-
mospheric fistulas occurred in 43 % of the subjects
undergoing DL, 18 % required the use of split-thickness
skin graft for the closure of their incision, and 50 %
developed incisional hernias that required delayed repair
[81]. Overall, 85 % of patients undergoing DL needed at
least another surgical intervention for the management of
their open abdomen, and compared with patients treated by
conservative measures and who survived, their hospital
stay was approximately 2 months longer.
Predictive models
Contrary to other authors [41, 76, 77], we did not identify
any significant difference between the values of predicting
scores in patients who underwent DL and the group treated
conservatively. We also failed to identify any variable that
could classify patients at risk of developing ACS as the
discriminating performance of all the severity scoring sys-
tems, such as APACHE II, SOFA, Ranson, Glasgow-Imrie,
and other predictors, including BMI had ROC curves with
AUC ranging only between 0.54 and 0.69. Dambrauskas
et al. [41] observed good discriminating characteristics for
APACHE II (AUC of 0.86) and for Glasgow-Imrie score
(AUC of 0.92). In their study, APACHE II cutoff of seven
had a sensitivity of 100 % and specificity of 60 % for the
diagnosis of ACS. Similarly, Glasgow-Imrie score greater
than three had a sensitivity of 83 % and specificity of 86 %.
Several factors may explain these variations as the inclusion
and exclusion criteria were different and the proportion of
patients with obesity was not specified. Therefore, inter-
preting and comparing the results is difficult considering the
heterogeneity of patient populations, methods, and outcome
reporting among all the various publications [11].
Strengths and limitations
One of the strengths of this study is that it is the largest
experience of patients affected by SAP as defined by the
Atlanta consensus conference and admitted in ICU at a
tertiary teaching center. Another important aspect is that
strict inclusion and exclusion criteria were applied and that
a power calculation was performed to assess the number of
subjects needed to identify possible differences for the
primary outcome between groups. Lastly, established and
clear definitions were used for the description of the study
population, clinical investigations, and surgical interven-
tions necessary for comparison with other studies.
Our study has several limitations due to its retrospective
design. During the time period of this study, there were no
protocols or established algorithms specific to our institution
for the management of patients affected by SAP. This led to
variations on the decision-making process among all the
physicians practicing in our ICU. As a consequence, SAP
patients did not undergo routine measurements of their
abdominal pressure unless they manifested deterioration of
their cardiopulmonary or renal function. The decision to
perform DL also was made selectively by the surgeon staff on
call once notified of the clinical deterioration of the patient or
the elevated value of the intra-abdominal pressure after con-
servative measures, such as the use of paralyzing agents and/or
aggressive diuresis failed [39]. Because there is still no uni-
form consensus in the literature on the indications for surgical
decompression in ACS associated with SAP [40, 74], it is very
likely that in many circumstances the value of intra-abdominal
pressure was not the only parameter used for the decision to
perform a DL. It is possible that in this cohort some patients
might have developed ACS, which likely a rare event because
the overall mortality of our study population was comparable
to that reported by other investigators who recommend routine
measurement of the intra-abdominal pressures in all patients
admitted in ICU for SAP [59, 82].
Conclusions
Mortality of patients with SAP has declined significantly
during the past few decades despite the increasing number of
obese patients in the general population. This study suggests
that obesity per se is not a negative prognostic factor for
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mortality in patients with SAP admitted to the ICU. DL is
associated with higher rates of fistulization and required
multiple surgical interventions for the management of the
open abdomen. Nevertheless, mortality rate of patients
undergoing DL was similar to patients who did not require
surgery suggesting that, in selected patients, DL might have
a significant role in reversing the declining course of SAP.
Because most of the current literature is retrospective and
from the experience of single-centers with limited number of
patients, prospective studies are necessary to assess the
impact of obesity, fat distribution, and other variables, such
as age or comorbidities, on mortality and morbidity of
patients with SAP requiring ICU admission.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Bradley EL, Dexter ND (2010) Management of severe acute
pancreatitis: a surgical odyssey. Ann Surg 251(1):6–17
2. Corfield AP, Cooper MJ, Williamson RC (1985) Acute pancre-
atitis: a lethal disease of increasing incidence. Gut 26(7):724–729
3. Mann DV, Hershman MJ, Hittinger R, Glazer G (1994) Multi-
centre audit of death from acute pancreatitis. Br J Surg 81(6):
890–893
4. McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW (1999)
High early mortality rate from acute pancreatitis in Scotland,
1984–1995. Br J Surg 86(10):1302–1305
5. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC
(1974) Prognostic signs and the role of operative management in
acute pancreatitis. Surg Gynecol Obstet 139(1):69–81
6. Imrie CW, Benjamin IS, Ferguson JC, McKay AJ, Mackenzie I,
O’Neill J et al (1978) A single-centre double-blind trial of Trasylol
therapy in primary acute pancreatitis. Br J Surg 65(5):337–341
7. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence
DE (1981) APACHE-acute physiology and chronic health eval-
uation: a physiologically based classification system. Crit Care
Med 9(8):591–597
8. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonc¸a A,
Bruining H et al (1996) The SOFA (Sepsis-related Organ Failure
Assessment) score to describe organ dysfunction/failure. On
behalf of the Working Group on Sepsis-Related Problems of the
European Society of Intensive Care Medicine. Intensive Care
Med 22(7):707–710
9. Spitzer AL, Barcia AM, Schell MT, Barber A, Norman J,
Grendell J et al (2006) Applying Ockham’s Razor to pancreatitis
prognostication: a four-variable predictive model. Ann Surg
243(3):380–388
10. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M
et al (1997) Relationship of necrosis to organ failure in severe
acute pancreatitis. Gastroenterology 113(3):899–903
11. Deenadayalu VP, Blaut U, Watkins JL, Barnett J, Freeman M,
Geenen J et al (2008) Does obesity confer an increased risk and/
or more severe course of post-ERCP pancreatitis? A retrospec-
tive, multicenter study. J Clin Gastroenterol 42(10):1103–1109
12. Yanovski SZ, Yanovski JA (2011) Obesity prevalence in the
United States–up, down, or sideways? N Engl J Med 364(11):
987–989
13. Pajuelo-Ramı´rez J, Miranda-Cuadros M, Campos-Sa´nchez M,
Sa´nchez-Abanto J (2011) Prevalence of overwight and obesity
among children under five years in Peru 2007–2010. Rev Peru
Med Exp Salud Publica 28(2):222–227
14. Oh I-H, Cho Y, Park S-Y, Oh C, Choe B-K, Choi J-M et al (2011)
Relationship between socioeconomic variables and obesity in
Korean adolescents. J Epidemiol 21(4):263–270
15. Misra A, Khurana L (2011) Obesity-related non-communicable
diseases: South Asians vs white Caucasians. Int J Obes 35(2):
167–187
16. Misra A, Shah P, Goel K, Hazra DK, Gupta R, Seth P et al (2011)
The high burden of obesity and abdominal obesity in urban
Indian schoolchildren: a multicentric study of 38,296 children.
Ann Nutr Metab 58(3):203–211
17. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003)
Overweight, obesity, and mortality from cancer in a prospectively
studied cohort of U.S. adults. N Engl J Med 348(17):1625–1638
18. Ma´rquez-Sandoval F, Macedo-Ojeda G, Viramontes-Ho¨rner D,
Ferna´ndez Ballart JD, Salas Salvado´ J, Vizmanos B (2011) The
prevalence of metabolic syndrome in Latin America: a systematic
review. Public Health Nutr 14(10):1702–1713
19. Funnell IC, Bornman PC, Weakley SP, Terblanche J, Marks IN
(1993) Obesity: an important prognostic factor in acute pancre-
atitis. Br J Surg 80(4):484–486
20. Martı´nez J, Sa´nchez-Paya´ J, Palazo´n JM, Aparicio JR, Pico´ A,
Pe´rez-Mateo M (1999) Obesity: a prognostic factor of severity in
acute pancreatitis. Pancreas 19(1):15–20
21. Martı´nez J, Sa´nchez-Paya´ J, Palazo´n JM, Suazo-Barahona J,
Robles-Dı´az G, Pe´rez-Mateo M (2004) Is obesity a risk factor in
acute pancreatitis? A meta-analysis. Pancreatology 4(1):42–48
22. De Waele B, Vanmierlo B, Van Nieuwenhove Y, Delvaux G
(2006) Impact of body overweight and class I, II and III obesity
on the outcome of acute biliary pancreatitis. Pancreas 32(4):
343–345
23. Halonen KI, Leppaniemi AK, Puolakkainen PA, Lundin JE,
Kemppainen EA, Hietaranta AJ et al (2000) Severe acute pan-
creatitis: prognostic factors in 270 consecutive patients. Pancreas
21(3):266–271
24. Papachristou GI, Papachristou DJ, Avula H, Slivka A, Whitcomb
DC (2006) Obesity increases the severity of acute pancreatitis:
performance of APACHE-O score and correlation with the
inflammatory response. Pancreatology 6(4):279–285
25. Tsai CJ (1998) Is obesity a significant prognostic factor in acute
pancreatitis? Dig Dis Sci 43(10):2251–2254
26. Frossard J-L, Lescuyer P, Pastor CM (2009) Experimental evi-
dence of obesity as a risk factor for severe acute pancreatitis.
World J Gastroenterol 15(42):5260–5265
27. Suazo-Barahona J, Carmona-Sa´nchez R, Robles-Dı´az G, Milke-
Garcı´a P, Vargas-Vora´ckova´ F, Uscanga-Domı´nguez L et al
(1998) Obesity: a risk factor for severe acute biliary and alcoholic
pancreatitis. Am J Gastroenterol 93(8):1324–1328
28. Larvin M, McMahon MJ (1989) APACHE-II score for assessment
and monitoring of acute pancreatitis. Lancet 2(8656):201–205
29. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M,
Bastos PG et al (1991) The APACHE III prognostic system. Risk
prediction of hospital mortality for critically ill hospitalized
adults. Chest 100(6):1619–1636
30. Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Localio SA
(1974) Objective early identification of severe acute pancreatitis.
Am J Gastroenterol 61(6):443–451
31. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new
method of classifying prognostic comorbidity in longitudinal
studies: development and validation. J Chronic Dis 40(5):373–383
32. Juneja D, Gopal PB, Ravula M (2010) Scoring systems in acute
pancreatitis: which one to use in intensive care units? J Crit Care
25(2):358.e9–358.e15
330 World J Surg (2013) 37:318–332
123
33. MedCalc (2011) http://www.mdcalc.com/ransons-criteria-for-
pancreatitis-mortality/. Accessed 11 Nov 2011
34. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985)
APACHE II: a severity of disease classification system. Crit Care
Med 13(10):818–829
35. Bradley EL (1993) A clinically based classification system for
acute pancreatitis. Summary of the international symposium on
acute pancreatitis, Atlanta, GA, September 11–13, 1992. Arch
Surg 128(5):586–590
36. Group APCW (2011) Revision of the Atlanta classification of
acute pancreatitis. http://pancreasclub.com/wp-content/uploads/
2011/11/AtlantaClassification.pdf. Accessed 10 Nov 2011
37. Venkatesan T, Moulton JS, Ulrich CD, Martin SP (2003) Prev-
alence and predictors of severity as defined by Atlanta criteria
among patients presenting with acute pancreatitis. Pancreas
26(2):107–110
38. SFAR Web Page (2012) http://www.sfar.org/scores2/apache22.
html. Accessed 13 Jan 2012
39. Cheatham ML, Malbrain MLNG, Kirkpatrick A, Sugrue M, Parr
M, De Waele J et al (2007) Results from the international con-
ference of experts on intra-abdominal hypertension and abdom-
inal compartment syndrome. II. Recommendations. Intensive
Care Med 33(6):951–962
40. Tao J, Wang C, Chen L, Yang Z, Xu Y, Xiong J et al (2003)
Diagnosis and management of severe acute pancreatitis compli-
cated with abdominal compartment syndrome. J Huazhong Univ
Sci Technol Med Sci 23(4):399–402
41. Dambrauskas Z, Parseliunas A, Gulbinas A, Pundzius J, Bar-
auskas G (2009) Early recognition of abdominal compartment
syndrome in patients with acute pancreatitis. World J Gastroen-
terol 15(6):717–721
42. Radenkovic DV, Bajec D, Ivancevic N, Bumbasirevic V, Milic N,
Jeremic V et al (2010) Decompressive laparotomy with temporary
abdominal closure versus percutaneous puncture with placement
of abdominal catheter in patients with abdominal compartment
syndrome during acute pancreatitis: background and design of
multicenter, randomised, controlled study. BMC Surg 10:22
43. Leppa¨niemi AK, Hienonen PA, Siren JE, Kuitunen AH, Lind-
stro¨m OK, Kemppainen EAJ (2006) Treatment of abdominal
compartment syndrome with subcutaneous anterior abdominal
fasciotomy in severe acute pancreatitis. World J Surg
30(10):1922–1924. doi:10.1007/s00268-006-0024-6
44. Leppa¨niemi A, Mentula P, Hienonen P, Kemppainen E (2008)
Transverse laparostomy is feasible and effective in the treatment
of abdominal compartment syndrome in severe acute pancreatitis.
World J Emerg Surg 3:6
45. Schachtrupp A, Fackeldey V, Klinge U, Hoer J, Tittel A, Toens C
et al (2002) Temporary closure of the abdominal wall (laparos-
tomy). Hernia 6(4):155–162
46. Fabian TC, Croce MA, Pritchard FE, Minard G, Hickerson WL,
Howell RL et al (1994) Planned ventral hernia. Staged manage-
ment for acute abdominal wall defects. Ann Surg 219(6):643–650
discussion 651–653
47. Fansler RF, Taheri P, Cullinane C, Sabates B, Flint LM (1995)
Polypropylene mesh closure of the complicated abdominal
wound. Am J Surg 170(1):15–18
48. Bleichrodt RP, Simmermacher RK, van der Lei B, Schakenraad
JM (1993) Expanded polytetrafluoroethylene patch versus poly-
propylene mesh for the repair of contaminated defects of the
abdominal wall. Surg Gynecol Obstet 176(1):18–24
49. Nagy KK, Fildes JJ, Mahr C, Roberts RR, Krosner SM, Joseph
KT et al (1996) Experience with three prosthetic materials in
temporary abdominal wall closure. Am Surg 62(5):331–335
50. Ghimenton F, Thomson SR, Muckart DJ, Burrows R (2000)
Abdominal content containment: practicalities and outcome. Br J
Surg 87(1):106–109
51. Olejnik J, Vokurka J, Vician M (2008) Acute necrotizing pan-
creatitis: intra-abdominal vacuum sealing after necrosectomy.
Hepatogastroenterology 55(82–83):315–318
52. Nordback I, Pessi T, Auvinen O, Autio V (1985) Determination
of necrosis in necrotizing pancreatitis. Br J Surg 72(3):225–227
53. Lee Y-H, Pratley RE (2005) The evolving role of inflammation in
obesity and the metabolic syndrome. Curr Diab Rep 5(1):70–75
54. Porter KA, Banks PA (1991) Obesity as a predictor of severity in
acute pancreatitis. Int J Pancreatol 10(3–4):247–252
55. Karimgani I, Porter KA, Langevin RE, Banks PA (1992) Prog-
nostic factors in sterile pancreatic necrosis. Gastroenterology
103(5):1636–1640
56. Abu Hilal M, Armstrong T (2008) The impact of obesity on the
course and outcome of acute pancreatitis. Obes Surg 18(3):326–328
57. Beger HG, Bittner R, Block S, Bu¨chler M (1986) Bacterial
contamination of pancreatic necrosis. A prospective clinical
study. Gastroenterology 91(2):433–438
58. De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A,
Peracchia A (1999) Discriminant power and information content
of Ranson’s prognostic signs in acute pancreatitis: a meta-ana-
lytic study. Crit Care Med 27(10):2272–2283
59. Talamini G, Bassi C, Falconi M, Sartori N, Frulloni L,
Di Francesco V et al (1996) Risk of death from acute pancreatitis.
Role of early, simple ‘‘routine’’ data. Int J Pancreatol 19(1):15–24
60. Lankisch PG, Schirren CA (1990) Increased body weight as a
prognostic parameter for complications in the course of acute
pancreatitis. Pancreas 5(5):626–629
61. Mery CM, Rubio V, Duarte-Rojo A, Suazo-Barahona J, Pela´ez-
Luna M, Milke P et al (2002) Android fat distribution as predictor
of severity in acute pancreatitis. Pancreatology 2(6):543–549
62. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW (2004)
Comparison of the release of adipokines by adipose tissue, adi-
pose tissue matrix, and adipocytes from visceral and subcutane-
ous abdominal adipose tissues of obese humans. Endocrinology
145(5):2273–2282
63. Connor S, Raraty MGT, Howes N, Evans J, Ghaneh P, Sutton R
et al (2005) Surgery in the treatment of acute pancreatitis–mini-
mal access pancreatic necrosectomy. Scand J Surg 94(2):135–142
64. Heinrich S, Scha¨fer M, Rousson V, Clavien P-A (2006) Evi-
dence-based treatment of acute pancreatitis: a look at established
paradigms. Ann Surg 243(2):154–168
65. Corfield AP, Cooper MJ, Williamson RC, Mayer AD, McMahon
MJ, Dickson AP et al (1985) Prediction of severity in acute
pancreatitis: prospective comparison of three prognostic indices.
Lancet 2(8452):403–407
66. Chatzicostas C, Roussomoustakaki M, Vlachonikolis IG, Notas
G, Mouzas I, Samonakis D et al (2002) Comparison of Ranson,
APACHE II and APACHE III scoring systems in acute pancre-
atitis. Pancreas 25(4):331–335
67. Ueda T, Takeyama Y, Yasuda T, Matsumura N, Sawa H, Nak-
ajima T et al (2007) Simple scoring system for the prediction of
the prognosis of severe acute pancreatitis. Surgery 141(1):51–58
68. Gardner TB, Vege SS, Chari ST, Pearson RK, Clain JE, Topazian
MD et al (2008) The effect of age on hospital outcomes in severe
acute pancreatitis. Pancreatology 8(3):265–270
69. Isenmann R, Rau B, Beger HG (1999) Bacterial infection and
extent of necrosis are determinants of organ failure in patients
with acute necrotizing pancreatitis. Br J Surg 86(8):1020–1024
70. Banks PA (1994) Acute pancreatitis: medical and surgical man-
agement. Am J Gastroenterol 89(8 Suppl):S78–S85
71. Isenmann R, Beger HG (1999) Natural history of acute pancre-
atitis and the role of infection. Baillieres Best Pract Res Clin
Gastroenterol 13(2):291–301
72. Johnson CD, Toh SKC, Campbell MJ (2004) Combination of
APACHE-II score and an obesity score (APACHE-O) for the
prediction of severe acute pancreatitis. Pancreatology 4(1):1–6
World J Surg (2013) 37:318–332 331
123
73. Frey CF, Zhou H, Harvey DJ, White RH (2006) The incidence
and case-fatality rates of acute biliary, alcoholic, and idiopathic
pancreatitis in California, 1994–2001. Pancreas 33(4):336–344
74. Tao H-Q, Zhang J-X, Zou S-C (2004) Clinical characteristics and
management of patients with early acute severe pancreatitis:
experience from a medical center in China. World J Gastroenterol
10(6):919–921
75. Al-Bahrani AZ, Abid GH, Holt A, McCloy RF, Benson J,
Eddleston J et al (2008) Clinical relevance of intra-abdominal
hypertension in patients with severe acute pancreatitis. Pancreas
36(1):39–43
76. De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F
(2005) Intra-abdominal hypertension in patients with severe acute
pancreatitis. Crit Care 9(4):R452–R457
77. Mentula P, Hienonen P, Kemppainen E, Puolakkainen P, Lep-
pa¨niemi A (2010) Surgical decompression for abdominal com-
partment syndrome in severe acute pancreatitis. Arch Surg
145(8):764–769
78. Gecelter G, Fahoum B, Gardezi S, Schein M (2002) Abdominal
compartment syndrome in severe acute pancreatitis: an indication
for a decompressing laparotomy? Dig Surg 19(5):402–404
discussion 404–405
79. Keskinen P, Leppa¨niemi A, Pettila V, Piilonen A, Kemppainen E,
Hynninen M (2007) Intra-abdominal pressure in severe acute
pancreatitis. World J Emerg Surg 2:2
80. Goverman J, Yelon JA, Platz JJ, Singson RC, Turcinovic M
(2006) The ‘‘Fistula VAC’’: a technique for management of
enterocutaneous fistulae arising within the open abdomen: report
of 5 cases. J Trauma 60(2):428–431 discussion 431
81. Hultman CS, Pratt B, Cairns BA, McPhail L, Rutherford EJ, Rich
PB et al (2005) Multidisciplinary approach to abdominal wall
reconstruction after decompressive laparotomy for abdominal
compartment syndrome. Ann Plast Surg 54(3):269–275 discus-
sion 275
82. Malbrain MLNG, Chiumello D, Pelosi P, Wilmer A, Brienza N,
Malcangi V et al (2004) Prevalence of intra-abdominal hyper-
tension in critically ill patients: a multicentre epidemiological
study. Intensive Care Med 30(5):822–829
332 World J Surg (2013) 37:318–332
123
